1. Strange, G, Playford, D, Stewart, S, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012; 98: 1805–1811.
Google Scholar | Crossref | Medline | ISI2. Dartevelle, P, Fadel, E, Mussot, S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637.
Google Scholar | Crossref | Medline | ISI3. Mathai, SC, Suber, T, Khair, RM, et al. Health-related quality of life and survival in pulmonary arterial hypertension. Ann Am Thorac Soc 2016; 13: 31–39.
Google Scholar | Crossref | Medline4. Jenkins, D, Madani, M, Fadel, E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26: 160111.
Google Scholar | Crossref | Medline5. Humbert, M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 2010; 19: 59–63.
Google Scholar | Crossref | Medline6. Freed, DH, Thomson, BM, Berman, M, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141: 383–387.
Google Scholar | Crossref | Medline | ISI7. Ghofrani, H-A, D'Armini, AM, Grimminger, F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319–329.
Google Scholar | Crossref | Medline | ISI8. Said, Q, Martin, BC, Joish, VN, et al. The cost to managed care of managing pulmonary hypertension. J Med Econ 2012; 15: 500–508.
Google Scholar | Crossref | Medline9. Burke, JP, Hunsche, E, Régulier, E, et al . Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study. Am J Manag Care 2015; 21(3 Suppl): s47–s58.
Google Scholar | Medline10. Anand, V, Roy, SS, Archer, SL, et al. Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the Nationwide inpatient sample database from 2001 through 2012. JAMA Cardiol 2016; 1: 1021–1029.
Google Scholar | Crossref | Medline | ISI11. Chen, H, Taichman, DB, Doyle, RL. Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc 2008; 5: 623–630.
Google Scholar | Crossref | Medline12. Armstrong, I, Billings, C, Kiely, DG, et al. The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients. BMC Pulmon Med 2019; 19: 67.
Google Scholar | Crossref | Medline13. Hoeper, MM. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2015; 24: 272–282.
Google Scholar | Crossref | Medline | ISI14. Favoccia, C, Kempny, A, Yorke, J, et al. EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome. Eur J Prevent Cardiol 2018; 26: 1338–1340.
Google Scholar | SAGE Journals15. McGoon, MD, Benza, RL, Escribano-Subias, P, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol 2013; 62(25 Suppl): D51–D59.
Google Scholar | Crossref | Medline16. Prins, KW, Thenappan, T. World Health Organization Group I Pulmonary hypertension: epidemiology and pathophysiology. Cardiol Clin 2016; 34: 363–374.
Google Scholar | Crossref | Medline | ISI17. Olsson, KM, Delcroix, M, Ghofrani, HA, et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 2014; 129: 57–65.
Google Scholar | Crossref | Medline | ISI18. DesJardin, JT, Kolaitis, NA, Kime, N, et al. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: baseline results from the Pulmonary Hypertension Association Registry. J Heart Lung Transplant 2020; 39: 945–953.
Google Scholar | Crossref | Medline19. Gray, MP, Kawut, SM. The Pulmonary Hypertension Association Registry: rationale, design, and role in quality improvement. Adv Pulmon Hypertens 2018; 16: 185–188.
Google Scholar | Crossref20. Ware, J, Kosinski, M, Keller, SD. A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.
Google Scholar | Crossref | Medline | ISI21. Loosman, WL, Hoekstra, T, van Dijk, S, et al. Short-form 12 or short-form 36 to measure quality-of-life changes in dialysis patients? Nephrol Dial Transplant 2015; 30: 1170–1176.
Google Scholar | Crossref | Medline22. Yorke, J, Corris, P, Gaine, S, et al. emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J 2014; 43: 1106–1113.
Google Scholar | Crossref | Medline | ISI23. Vyas, DA, Eisenstein, LG, Jones, DS. Hidden in plain sight – reconsidering the use of race correction in clinical algorithms. N Engl J Med 2020; 383: 874–882.
Google Scholar | Crossref | Medline24. Guillevin, L, Armstrong, I, Aldrighetti, R, et al. Understanding the impact of pulmonary arterial hypertension on patients and carers lives. Eur Respir Rev 2013; 22: 535.
Google Scholar | Crossref | Medline25. McGoon, MD, Ferrari, P, Armstrong, I, et al. The importance of patient perspectives in pulmonary hypertension. Eur Respir J 2019; 53: 1801919.
Google Scholar | Crossref | Medline26. Doward, LC, McKenna, SP. Defining patient-reported outcomes. Value Health 2004; 7 Suppl 1: S4–S8.
Google Scholar | Crossref | Medline27. Schipper, HCJ, Powell, V. Definitions and conceptual issues. In: Spiker, B (ed.) Quality of life assessments in clinical trials. New York: Raven Press, 1990, pp.11–24.
Google Scholar28. McCabe, C, Bennett, M, Doughty, N, et al. Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest 2013; 144: 522–530.
Google Scholar | Crossref | Medline | ISI29. Ivarsson, B, Hesselstrand, R, Rådegran, G, et al. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Chron Respir Dis 2019; 16: 1479972318787906.
Google Scholar | SAGE Journals | ISI30. Cole, E, Armstrong, I, Cutts, K. Psychological differences between people with PAH, IPAH and CTEPH. Eur Respir J 2016; 48(suppl 60): PA2431.
Google Scholar31. Newnham, M, Bunclark, K, Abraham, N, et al. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Eur Respir J 2020; 56: 1902096.
Google Scholar | Crossref | Medline32. Borgese, M, Badesch, D, Bull, T, et al. EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR. Eur Respir J 2021; 57: 2000414.
Google Scholar | Crossref | Medline33. Jamieson, SW, Kapelanski, DP, Sakakibara, N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76: 1457–1464.
Google Scholar | Crossref | Medline | ISI34. Galiè, N, Humbert, M, Vachiery, J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Int Soc Heart Lung Transplant (ISHLT) 2015; 46: 903–975.
Google Scholar35. Delcroix, M, Lang, I, Pepke-Zaba, J, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 2016; 133: 859–871.
Google Scholar | Crossref | Medline | ISI36. Gall, H, Hoeper, MM, Richter, MJ, et al. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev 2017; 26: 160121.
Google Scholar | Crossref | Medline37. Kirson, NY, Birnbaum, HG, Ivanova, JI, et al . Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population. Appl Health Econ Health Policy 2011; 9: 377–387.
Google Scholar | Crossref | Medline38. George, MG, Schieb, LJ, Ayala, C, et al. Pulmonary hypertension surveillance: United States, 2001 to 2010. Chest 2014; 146: 476–495.
Google Scholar | Crossref | Medline | ISI